logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Bladder cancer: frontline maintenance avelumab prolongs survival

Results from phase 3 JAVELIN Bladder 100 show survival benefit in PD-L1–positive disease.